Introduction
Atopic eczema (AE) affects up to 20% of children in developed countries 1 . The quality of life impact of eczema can be high for both children and their families 2 . Effective parental management minimises disease severity and improves child and family quality of life 3. This requires a degree of knowledge, skill and confidence from the parent; confidence is akin to the psychological concept of self-efficacy. Self-efficacy (SE)
is a concept derived from Bandura's Social Learning Theory that refers to an individual's belief in their own capacity to positively affect their health behaviour 4, 5 . Reviews 6, 7, 8 and policy 9 highlight the value of SE in effective self-management of chronic disease. However, a gap in the literature is evident since little attention has been given to its application within a dermatological context and the self-efficacy of carers, although there are exceptions 10 . A systematic review of educational interventions for child eczema has revealed both a lack of theoretical underpinnings and methodological limitations 11 . The development of an outcome measure of parental self-efficacy in eczema care provides a basis for evaluating interventions directed towards enhancing parental confidence in managing their child's condition. This study set out to develop and then validate a tool to measure parental self-efficacy and test the feasibility of its clinical application through a wider study evaluating an Eczema Education Programme directed at supporting parents' in managing their child's eczema 12, 13 .
A recent systematic review 11 found no controlled studies evaluating self-efficacy outcomes in the parental management of eczema to date. With the exception of a range of severity measures 14 the most frequently used outcome tools applied to evaluate clinical and research interventions for childhood AE, measure dermatology specific child 15 and infant 16 quality of life and family impact 2 . These child and family outcome tools measure quality of life impact but do not give an indication of the educational support needs of parents managing child eczema. Accurate assessment of parental education and support needs is a critical factor in ensuring that interventions are directed toward increasing the self-efficacy required to enable parents to manage their child's AE as effectively as possible.
'The General Self-Efficacy Scale (GSES) has been developed 17 and validated 18, 19 with large scale populations.
It is useful for assessing an individual's belief in how they can be self-efficacious. However, the items within the GSES lack specificity to clinical contexts 20 , such as childhood eczema. A disease or domain-specific measure of perceived self-efficacy is likely to be more useful than a general measure as they will reveal specific deficits that will enable targeted and personalised support by the healthcare professional 20, 21 .
Examples of disease-specific parental self-efficacy scales include studies of parents of children with asthma 22 , preterm neonates 23 , children with chronic pain 24 and with minor child illness 25 . Robust tool development continues on scales to measure self-efficacy to manage chronic disease 26 .
The Parental Self-Efficacy with Eczema Care Index (PASECI) was developed as an outcome measure for a study investigating the feasibility and impact of a structured education programme, termed the Eczema Education Programme (EEP) 12 , which was designed for parents of children with eczema. Through the initial phase of delivery of the EEP we planned to develop and validate this scale 13 . The EEP service offered parents access to standardised, evidence-based eczema education delivered in both specialist centres and the community 12 . The EEP sample provided the basis for the validation of the PASECI scale.
Objective
To develop and test the validity, reliability and sensitivity of a new outcome measure designed to assess parental self-efficacy in managing their child's eczema and for use as a self-report outcome measure to determine pre and post changes in eczema educational intervention studies.
Materials and Methods

Development and testing of the Index (PASECI)
The design of PASECI was informed by Bandura's theory of SE 5 , guidance on construction of SE scales 20, 21 , and a review of published research studies that had employed a self-efficacy measurement scale 4, 22, 23, 24, 25, 26 . A literature review was used to enhance content and construct validity. Existing self-efficacy scales from clinical areas outside the dermatology field were reviewed for relevant questions, content and wording that was suitable for application to the context of parental management of child eczema management. From this review, a set of 40 questions relevant to the disease-specific aspects of personal efficacy in eczema care were developed and grouped into four theoretical domains. Face and content validity was achieved by circulating successive iterations of the scale with the EEP expert steering group until the 40 item prototype (V7) scale was produced (see Appendix 1); this version was tested. Each item could be scored on an 11 point scale (0 = not confident to 10 = very confident) to increase the response options and ability to distinguish between smaller differences on the scale, as well as to avoid heaping at the mid-point, as can be found on five point scales 20 Participants and sampling: We sought to recruit as many parents as possible from the 356 who attended the EEP programme over a 19 month period. A purposive or non-probability sample (n=242) (described below) was obtained from the full set of EEP study respondents who completed the baseline questionnaire; these were representative of the parents attending the EEP . As this was a new tool, we were unable to estimate an effect size and so undertake a power estimate. The inclusion criteria were the same as for the entry to the EEP, that is, 1) parent of child (0-16) with an eczema diagnosis; 2) family understanding the English language; and 3) child attending host hospital services or lived in, or had a GP in the local primary care community.
The PASECI questionnaire was completed by the parents one week before attending the educational intervention (EEP) and 4 weeks post-intervention to enable measurement of any change in parental selfefficacy. The modal sub-group were parents of infants (0-4 years), who constituted 88% of this sample. The study location was a large inner city UK metropolitan borough characterised by high levels of mobility, ethnic diversity and social deprivation. ii) Item (question) by item analysis of change was used to investigate any variable change before and after the EEP using Sign tests for the 40 pre-post-tests, as the data were of an ordinal nature. A 0.1%
Bonferroni significance level was used to address the issue of multiple significance testing.
iii) Factor analysis was used to verify appropriateness of domains or sections within the index. This was applied to the pre-intervention data using the Principal Components Method, followed by Varimax rotation. Following the results of the first stage of analysis, 6 items (questions) with substantial proportions of missing data were excluded (10%). Only 34 of the 40 items were included in the initial factor analyses. After the initial results, a further reduction to 29 items was made, fixing the number of factors extracted at four. As a further check on the consistency of the factor solution, the Maximum Likelihood and Principal Axes Methods of factor extraction were applied to the list of 29
items. Following factor analysis we transferred two items to new domains in the prototype scale, producing the final scale; this produced a scale with a reduced number of questions, within each of the four domains of the index.
iv) Reliability analysis involved examining the internal consistency of items; this was undertaken on the final scale using the Cronbach alpha statistic.
v)
Correlations were used to investigate the relationship of parental self-efficacy to both child eczema severity and their quality of life. We wanted to test the hypothesis that improvements in parental self-management and therefore more effective adherence to an optimal management regimen may be related to improved child outcomes. For cases pertaining to 0-4 year old (infants) only, Pearson correlations were calculated between these four domain total scores of the PASECI and the Patient Orientated Eczema Measure (POEM) 27 , Infant Dermatitis Quality of Life (IDQOL) Index 16 .
Results
The following results derive from the five stages of analysis within the validation process and as such are presented in corresponding sequence. This data relates to the 242 parental cases, who were representative of the sample of parents attending the EEP 12 .
The actual sample size for each element of the analysis varied because of missing item data and the smaller number of available cases after education was delivered.
(i) Descriptive statistics: Across all questions in our original prototype index of 40 items, the median scores ranged from 5-9, with lower quartiles ranging from 2-6 and upper quartiles from 8-10 (the maximum possible item rating). The mode was the maximum possible rating of 10 for over half of the items. However, there was no floor or ceiling effects so all items were useful for discriminating between participants. Six items had missing data for at least 25 (10%) out of 242 cases: these related to the child's engagement in their care, which would be more limited for infants (questions (Q) 12, 13, 14, 16), telling the nurse when you disagree with them (Q26) and the impact of feeling under pressure from work (Q31) due to the possibility of not being in paid work.
ii) Scale's sensitivity to change: After controlling for multiple testing by setting a significance level of 0.1%, a significant improvement (p<0.001) was found for all 40 items (number analysed ranged from n=93 to 130).
The pre-intervention responses for some items were skewed towards the top end of the scales and so little improvement was possible. These results indicate that the PASECI is sensitive to change. Table 1 ); those <0.4 were omitted. In summary, the factor analysis revealed that the four factor or domain structure of the index or scale was appropriate and viable, there was scope to reduce the number of items (questions) to 29 and there was no need to have questions differentiating between different health professionals. A review of items following factor analysis highlighted opportunities to move some items to more appropriate domains. The final 29-item scale is given in Figure 1 . Table 2 presents sample correlations and confidence intervals between the total scores over items within each of the four PASECI domains in the final 29 item scale and the POEM (patient orientated severity measure) and IDQOL (infant quality of life) scale totals to explore if changes in parental self-efficacy may vary with the child outcomes, eczema symptom severity and quality of life respectively. As Q12, 13, 14 and 16 were removed from the original 40-item PASECI and are potentially relevant to older children, only cases pertaining to children aged 0-4 were included in this analysis. All correlations in Table 2 are very weak and so the relationship of the PASECI domain scores with a common measure of eczema severity and quality of life has not yet been established.
v) Correlations of parental self-efficacy and other outcome measures child outcomes:
Discussion
The PASECI scale has face, content and construct validity and reliability (internal consistency). In the final 29-item scale, the rigour and usability of the tool was improved by removing items not relevant to infants (the modal group) and collapsed to unifying responses to questions relating to engaging with health professionals, rather than differentiating the type, due to indications that the factor structure would be the same. The data indicates that the PASECI is sensitive to change. During the testing period linked to the EEP evaluation quantitative data was collected alongside qualitative from focus groups on parental self-efficacy with eczema care. Focus group (qualitative) data from parents' post-intervention, showed clear themes, revealing enhancement of self-efficacy, when PASECI was used as an outcome measure, strengthening the indications of validity 13 . This combination of data (triangulation) was used to enhance the validity of the tool. The relationship of parental self-efficacy to the child clinical outcomes, quality of life and disease severity,
has not yet been established. This is surprising given that efficacious eczema management by parents should increase the probability of improvements in child clinical outcomes and therefore we believe this hypothesis warrants further testing.
The only similar and theoretically relevant outcome measure reported in dermatology was a German selfefficacy scale (SEND) for parents of pre-school children with AE
29
. The validity of SEND questionnaire's 9
items were informed by theoretical concepts and parental interviews. It is claimed to be valid and reliable; however, the scale was not published in the paper and thus it is difficult to adequately appraise. Also, its use in English language countries is not established. Hence the PASECI tool addresses a gap in the literature on self-efficacy scales applied to the dermatology field. Specifically, it provides an effective method to assess parental education needs and to evaluate the impact of interventions designed to promote effective management of their child's eczema.
Analysis of some items from the prototype 40-item PASECI V7 was undertaken by Mitchell and Fraser. 30 They sought to develop a suite of valid and reliable research instruments to appraise parents' self-efficacy for performing AE management tasks, outcome expectations of such tasks, and self-reported task performance in a community sample of parents of children with AE. The validity and reliability of PASECI was additionally confirmed in Mitchell and Fraser's analysis, however, their analysis excluded the domain 'Managing personal challenges' and as such this process was incomplete 30 .
We had considered the scope to include an item on steroid phobia, as a factor affecting the confidence of parent's in managing treatment effectively, and therefore the achievement of suitable adherence, however, we decided not to do so as the reliability analysis highlighted that the questions on confidence in correctly using steroids and successfully using moisturisers remain, and as separate items within the scale.
The scale validation process has some limitations. Despite the demonstrable strengths in validity and reliability, further investigation of inter-relationship between PASECI and DFI scores, and clinical severity is required to more fully test its relationship to other commonly used and potentially related measures of quality of life and clinical severity. One possible explanation for the low correlation reported from our wider study previously 11 is that disease severity was not a criterion for access to EEP and the quality of life impact we reported at baseline was low-moderate. Another explanation may be linked to the observation that many of the newly diagnosed infants did not have severe eczema; this is documented in our EEP evaluation paper (p633) 13 & 27 . Another limitation is that there is reliance on self-reported data, which may affect the fidelity of the results. The generalizability of the findings is potentially confined to a UK metropolitan population, although validity of 25 of the main scale items has been established within an Australian study 30 . Although the PASECI can be effectively used to measure changes in parental selfefficacy with eczema care, further developmental work is required on the categorisation of high and low PASECI score bandings to enhance the index's utility.
The PASECI is of value as an outcome measure in studies designed to test the effectiveness of structured education or other interventions to improve parents' management of their child's eczema 13 . It also has the potential to provide a more accurate view of the efficacy of educational interventions directed towards parents of children with eczema. The final PASECI could be usefully applied by clinicians as an assessment and evaluation scale in the dermatology setting. By obtaining a baseline measure of parental self-efficacy to manage their child's AE, they could target parents more likely to respond to self-efficacy focused interventions, such as parental teaching about medications, to those with low self-efficacy baseline scores.
With the drive to harmonise the assessment of the clinical signs of eczema and derive a core set of outcomes 31 , there is scope to consider the effective measurement of a wider range of key psychological factors that have bearing on the efficacy of eczema management, especially in explanatory trials. Selfefficacy may be considered as an intermediate outcome measure that has bearing on clinical outcomes.
A recent and comprehensive review of self-efficacy interventions 8 and a robust study 26 by the same group highlights the significant potential of self-efficacy based programmes to improve the quality of life of patients with chronic diseases. We contend that the recommendations made are of equal relevance to parents of children with chronic skin diseases, such as eczema, as they have a key role in their effective management. Accurate measurement of parental self-efficacy and the evaluation of self-efficacy based interventions are of high importance in the promotion of effective management of childhood chronic dermatoses. Assessment of parental self-efficacy with eczema care provides a basis for enhancing concomitant educational support to the use of existing therapy that requires self-management.
MANAGING PERSONAL CHALLENGES WHEN CARING FOR YOUR CHILD WITH ECZEMA:
How confident do you feel that you can manage your child's eczema in these situations? 
